Related Experiment Video
Updated: May 12, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
13.5K
Hypertrophic cardiomyopathy-related left ventricular pseudoaneurysm: A case report
Katsuya Hashimoto1, Hiroyuki Yamamoto1,2, Atsushi Harada3
1Department of Cardiovascular Medicine, Narita-Tomisato Tokushukai Hospital, Chiba, Japan.
Heliyon
|June 13, 2024
Summary
This case study presents the first instance of hypertrophic cardiomyopathy-related left ventricular pseudoaneurysm (LVP) mimicking cardiac rupture. Early diagnosis and management of HCM-related LVP are critical for patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Medical Imaging
Background:
- Left ventricular pseudoaneurysm (LVP) is a rare but fatal complication of left ventricular rupture, distinct from true aneurysms often seen in hypertrophic cardiomyopathy (HCM).
- Differentiating LVP from true aneurysms is critical due to differing natural histories and treatment strategies.
- The incidence and management of HCM-related LVP remain largely unknown, necessitating further investigation.
Observation:
- An 88-year-old male presented with chest pain, echocardiography revealed left ventricular hypertrophy and outflow tract obstruction.
- Cardiac computed tomography angiography (CCTA) was crucial in diagnosing LVP with signs of impending cardiac rupture.
- Despite medical management, the patient's condition deteriorated, leading to semi-urgent surgical repair.
Findings:
- Surgical findings and subsequent pathology confirmed LVP with adjacent myocardial tissue consistent with HCM.
- This represents the first reported case of HCM-related LVP presenting as impending cardiac rupture.
- Postoperative hypotension was noted, and the patient ultimately died of non-occlusive mesenteric ischemia.
Implications:
- This case underscores the importance of considering HCM-related LVP in patients with left ventricular outpouching.
- CCTA plays a vital role in the diagnosis of LVP.
- Accumulating data on the management of HCM-related LVP is essential for future clinical practice.
Keywords:
Cardiac computed tomography angiographyHypertrophic cardiomyopathyLeft ventricular outpouchingLeft ventricular pseudoaneurysmMid-ventricular obstructionMore Related Videos
Related Concept Videos
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...